Galapagos Nv

Janssen Pharmaceutica Nv

Boehringer Ingelheim International Gmbh

Other

Gilead Sciences, Inc.

Burritt, Andrew

Paul John Edwards

Martin James Inglis Andrews

Wolfgang Schmidt

Mark Stuart Chambers

Kim Louise Hirst

Juha Andrew Clase

Angus MacLeod

Gregory Bar

Veronique Birault

Philip Huxley

Clifford John Harris

Reginald Christophe Xavier Brys

Sébastien Laurent Xavier Martina

Xueliang Tao

Friedrich Erich Karl Kroll

Andrew Burritt

Pierre Louis Beaulieu

Christiane Yoakim

Jean Rancourt

Youla S Tsantrizos

Murray D Bailey

Bruno Simoneau

Teddy Halmos

Martin Duplessis

Clint A James

Claudio F Sturino

Marc-Andre Poupart

Anne-Marie Faucher

Lee Fader

Martin Poirier

Christian Brochu

Stephen Kawai

Sebastien Morin

Patrick Deroy

Mathieu Parisien

Timothy A Stammers

Eric Malenfant

Grégory Louis Joseph Bar

Jean-Eric Lacoste

Louis Morency

Martin Tremblay

Araz Jakalian

Brigitte Allart

Joannie Minville

Punit-Kumar Bhardwaj

Ian Gregory Smith

Compounds of formula (I): wherein c, X, Y, R, Rand Rare defined herein, are useful as inhibitors of HIV replication. 

Inhibitors of human immunodeficiency virus replication

Compounds of formula (I): wherein R, R, A, A, A, A, X and Y are as defined herein, are useful as inhibitors of HIV replication.

Inhibitors of HIV replication

Compounds of formula I: wherein X, R, R, Rand Rare defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

Viral polymerase inhibitors

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Novel triazolopyridine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.

Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

Novel imidazolopyridine compounds are disclosed that have a formula represented by the following:  The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.

Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following:  The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.

Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Novel imidazo[-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

A server implements a marketing method. The server may receive a wireless call or message originating at a given facility and return a menu of choices particular to that facility. On receiving a choice selected from said menu, the server may return one or more messages with information particular to a part of said given facility. The information may be a marketing incentive, marketing information, or a promotion.

Marketing method

Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.

Growing community of inventors

Laval, Canada

Paul John Edwards